The system combines an anatomically shaped implant which supports bone conservation and is designed for stable initial fixation with OsseoTi Porous Metal.
Designed with or without integrated fixation and options to gain up to 30 degrees of angulation, the implant can be adjusted intra-operatively, to fit each patient’s needs.
FDA approved an expansion to its Phase I/II clinical program to include three spinal fusion indications and tripling the number of investigational sites in the U.S.